Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
-50.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SmileDirectClub, Inc. (SDCCQ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 50.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -26.2%, EPS growth of +18.4%, a dividend yield of 0.0%. What stands out right now is revenue -26.2%, EPS +18.4%, free cash flow +15.3% with operating margin -55.7% and ROIC -53.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SDCCQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SDCCQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SDCCQ Max Drawdown
-99.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SDCCQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$423.2M
-43.6% YoY
FY Net Income
-$74.8M
+34.7% YoY
Free Cash Flow
-$162.2M
+61.3% YoY
Revenue Growth
-26.2%
EPS Growth
+18.4%
Gross Margin
69.6%
Net Margin
-18.4%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 471M | 638M | 657M | 750M | 423M |
| Gross Profit | 328M | 417M | 418M | 556M | 285M |
| Operating Income | -262M | -254M | -185M | -490M | -46M |
| EBITDA | -186M | -241M | -174M | -492M | -52M |
| Net Income | -86M | -102M | -78M | -115M | -75M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 93M | 225M | 317M | 318M | 314M |
| Total Assets | 597M | 795M | 885M | 886M | 555M |
| Total Liabilities | 982M | 929M | 651M | 427M | 257M |
| Shareholder Equity | 111M | 171M | 308M | 333M | 298M |
| Total Debt | 872M | 766M | 437M | 209M | 157M |
| Net Debt | 779M | 541M | 120M | -110M | -157M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
120M
+61.5% YoY
Capital Expenditures
42M
+60.7% YoY
Free Cash Flow
162M
+61.3% YoY
Key ratios
Gross Margin
69.6%
Operating Margin
-55.7%
Net Margin
-18.4%
ROE
-61.1%
Debt / Equity
7.83x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.